FDA

Wisconsin Vape Shop Owners Fight New Law Threatening Their Businesses Amid FDA Approval Controversy

by

CUDAHY, Wis. — Vape shop owners in Wisconsin are contesting a state law that prohibits the sale of vaping products not authorized by the Food and Drug Administration, with potential fines escalating to $1,000 daily for non-compliance starting September 1. Jamal Abujad, 42, who owns Distro Guys Wholesale in Cudahy, fears the new regulations could cripple his business. “I used to smoke two packs a day. Now that I vape, I feel healthier,” Abujad said. He expressed concern that the law could jeopardize the livelihoods of thousands. “If this law goes through, three thousand vapor … Read more

Judge Directs CDC, FDA to Reinstate Websites Following Presidential Directive on Gender Issues

by

A federal judge has recently mandated that the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) reinstate several web pages removed following an executive order regarding gender identity signed by former President Donald Trump. The ruling, issued in San Francisco, underscores a crucial confrontation between the judiciary and executive interpretations of regulations affecting gender and health information. The contested web pages, which included vital health information for the LGBTQ+ community, were taken down after Trump’s executive order aimed at certain gender identity protections dictated by health and human services … Read more

Federal Judge Orders Immediate Restoration of CDC, FDA Health Data Removed Under Trump Directive

by

Washington — A federal judge has intervened to reinstate several health webpages and data removed under a directive from President Donald Trump aimed at eliminating content related to gender ideology. On Tuesday, U.S. District Judge John Bates issued a temporary restraining order in favor of Doctors for America. The group, comprising healthcare professionals, argued the removal of critical medical resources from the Department of Health and Human Services, Centers for Disease Control and Prevention, and Food and Drug Administration websites impeded their ability to treat patients and carry out research. Doctors for America brought the … Read more

Eli Lilly Joins Lawsuit to Defend Drug Patent Against Compounding Pharmacies Amid FDA Regulatory Dispute

by

Washington, D.C. — Pharmaceutical giant Eli Lilly has entered the legal fray by filing a motion on January 1 to join a lawsuit challenging the U.S. Food and Drug Administration’s (FDA) decision regarding the manufacturing of generic versions of GLP-1 drugs, such as those Lilly markets under the names Mounjaro and Zepbound. The company asserts significant stakes in the ongoing legal battle over whether compounding pharmacies may continue creating generics previously necessitated by drug shortages. The initial lawsuit was launched in October by the Outsourcing Facilities Association and FarmaKeio Custom Compounding, a Texas-based compounding pharmacy. … Read more